Sec. 844. Risk management for Department of Defense pharmaceutical supply chains

67 words·~1 min read·/bill/118/hr/8070/eh/section-844

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Section 860(a) of the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023 ( Public Law 117–263 ; 136 Stat. 2734; 10 U.S.C. 3241 note prec.) is amended— in paragraph (2), by inserting , temperature exposure throughout the supply chain process, before and final drug products ; and in paragraph (3)(A), by inserting , including temperature monitoring throughout the supply chain after of drugs .

Connectionstraces to 2

Traces to 2 documents

public-private-law

James M. Inhofe National Defense Authorization Act for Fiscal Year 2023
Public Law 117-263

U.S. Code

Design-build selection procedures
§ 3241

1 reference not yet in our index

136 Stat. 2734

Citation graph

cites case law

Sec. 844

Risk management for Department of Defense pharmaceutical supply chains

Pub. L.Public Law 117-263

U.S.C.§ 3241

Stat.136 Stat. 2734

Cites 3Cited by 0 across 0 sources